A predictive model for aggressive non-Hodgkin's lymphoma

Margaret A. Shipp, David P. Harrington, J R Anderson, +24

Lymphoid NeoplasiaAggressive Non-hodgkinMedicinePathologyLymphatic Disease +3

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Tim Lister, D. Crowther, S.B. Sutcliffe, +6

Journal of Clinical Oncology

EngineeringDiagnosisPathologyCotswolds MeetingLiver Function +16

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

MH Bronchud, J.H. Scarffe, Nicholas Thatcher, +5

British Journal of Cancer

Phase I/ii StudyMedicineGranulocyteImmunologyIntensive Chemotherapy +5

Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

M. van Glabbeke, A.T. van Oosterom, J. Wolter Oosterhuis, +7

Journal of Clinical Oncology

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Ruth Pettengell, Howard Gurney, DP Deakin, +5

Blood

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Ruth Pettengell, Howard Gurney, DP Deakin, +5

Blood

Failure to preserve fertility in patients with Hodgkin's disease

Jonathan Waxman, R.G. Ahmed, Duncan L. Smith, +8

Cancer Chemotherapy and Pharmacology

InfertilityFertilityReproductive HealthGynecologyFertility Tracking +4

Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials

Lesley Stewart, Kristian Aabo, P I Adnitt, +16

Advanced Ovarian CancerMedicineMetronomic TherapyRandomised Clinical TrialsClinical Trials +8

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

MH Bronchud, Anthony Howell, D. Crowther, +3

British Journal of Cancer

Breast OncologyMedicineGynecologyAdvanced BreastBreast Cancer +6

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

Jeanette Lundin, Anders Österborg, G. Brittinger, +16

Journal of Clinical Oncology